bpc-157 subcutaneous injection sites Peptide bpc-157 injection site guidelines Subcutaneous
Description
Retrieved October 19, 2023
Unlike full-length growth hormone, AOD-9604 does not bind to the classical hGH receptor, does not elevate IGF-1 levels, and does not impair insulin sensitivity or glucose tolerance
But it comes with important caveats: lack of FDA approval, variability risks, and transitional regulatory changes
Temperature for Reconstituted Solutions: For short-term use (days to a few weeks), refrigeration at 2C to 8C (36F to 46F) is generally acceptable
Nonsteroidal anti-inflammatory drugs (NSAIDs): Drug safety communication avoid use of NSAIDs in pregnancy at 20 weeks or later
